These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6682326)

  • 1. [Treatment of essential hypertension with the beta-receptor antagonist carteolol. A multicenter study].
    Rosprich G; Sölter H
    Arzneimittelforschung; 1983; 33(2a):334-9. PubMed ID: 6682326
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hypotensive effect of carteolol in patients with essential hypertension].
    Beythien RD
    Arzneimittelforschung; 1983; 33(2a):330-3. PubMed ID: 6682325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical experiences with carteolol in patients with essential hypertension].
    Viehmann P
    Arzneimittelforschung; 1983; 33(2a):322-5. PubMed ID: 6340701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Carteolol in essential hypertension. Dose range study and controlled open trial in comparison with pindolol].
    Werning C
    Arzneimittelforschung; 1983; 33(2a):325-30. PubMed ID: 6682324
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of long-term treatment with low doses of carteolol on cardiovascular regulatory functions in elderly patients with mild hypertension.
    Shimada K; Kawamoto A; Matsubayashi K; Chikamori T; Kuzume O; Ozawa T
    Clin Ther; 1990; 12(2):118-24. PubMed ID: 1972351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical significance of the ISA (intrinsic sympathomimetic activity) of the beta blocker carteolol].
    Lohmöller G; Conca W; Pötzl C
    Med Klin (Munich); 1987 Sep; 82(19):647-50. PubMed ID: 3683326
    [No Abstract]   [Full Text] [Related]  

  • 7. Carteolol treatment of essential hypertension: a long-term study of safety and efficacy.
    Luther RR; Maurath CJ; Klepper MJ; Peckinpaugh RO; Ringham GL
    J Int Med Res; 1986; 14(4):175-84. PubMed ID: 3758467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical experiences in patients with coronary heart disease and angina pectoris].
    Sölter H
    Arzneimittelforschung; 1983; 33(2a):304-10. PubMed ID: 6404286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ambulatory blood pressure and heart rate during once-daily, randomized, crossover administration of carteolol and atenolol.
    Saito K; Furuta Y; Sano H; Yokoyama M; Fukuzaki H
    Clin Ther; 1994; 16(2):181-90. PubMed ID: 8062314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of intrinsic sympathomimetic activity of the beta blocker carteolol. II: Comparative studies of carteolol and pindolol in patients with bradycardia].
    Lohmöller G; Middeke M; Mrowka C; Pötzl C; Renner W; Zoller W
    Med Klin (Munich); 1989 Feb; 84(2):81-5. PubMed ID: 2651861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antihypertensive treatment with captopril or carteolol in elderly patients].
    Murai A; Miyata S; Miyahara T; Sako Y
    Nihon Ronen Igakkai Zasshi; 1987 Jan; 24(1):35-40. PubMed ID: 3298752
    [No Abstract]   [Full Text] [Related]  

  • 12. Carteolol and penbutolol for hypertension.
    Med Lett Drugs Ther; 1989 Jul; 31(797):70-1. PubMed ID: 2568577
    [No Abstract]   [Full Text] [Related]  

  • 13. Antihypertensive effect of carteolol in thiazide-treated hypertensive subjects.
    Velasquez MT; Byrne D; Hoffmann RG
    J Clin Pharmacol; 1985; 25(8):601-6. PubMed ID: 3908501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled study of the antihypertensive effect of carteolol, a new beta-adrenergic receptor blocking drug, in combination with hydrochlorothiazide and amiloride.
    Tarkiainen A; Saraste K; Seppälä T; Gordin A; Auvinen J
    Eur J Clin Pharmacol; 1981 Mar; 19(4):239-44. PubMed ID: 6116605
    [No Abstract]   [Full Text] [Related]  

  • 15. [Carteolol in the treatment of open-angle glaucoma].
    Gorgone G; Randazzo S; Spina F
    Ophtalmologie; 1988; 2(5):431-3. PubMed ID: 3244464
    [No Abstract]   [Full Text] [Related]  

  • 16. Circadian blood pressure change after carteolol chloride in younger and older hypertensive patients.
    Kuwajima I; Suzuki Y; Kuramoto K; Kawamura H; Otsuka K
    Clin Ther; 1993; 15(2):338-46. PubMed ID: 8519042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-dependent antihypertensive effect of carteolol--a beta-adrenoceptor antagonist with partial agonist activity.
    Giles TD; Sander GE; Kaneish A; Quiroz AC
    Clin Pharmacol Ther; 1984 Mar; 35(3):301-6. PubMed ID: 6697637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carteolol, an antihypertensive beta-blocker with intrinsic sympathomimetic activity, reduces ECG evidence of left ventricular hypertrophy.
    Rosales OR; Sander GE; Roffidal L; Given MB; Giles TD
    Chest; 1989 Jan; 95(1):43-7. PubMed ID: 2521204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study of penbutolol and atenolol in the therapy of essential hypertension].
    Fallo F; Pisani G; Mantero F
    Clin Ter; 1988 Jun; 125(6):425-30. PubMed ID: 2973948
    [No Abstract]   [Full Text] [Related]  

  • 20. [Efficacy and tolerability of tertatolol in the treatment of mild to moderate arterial hypertension. Results of a French multicenter study with 2,338 patients treated over one year].
    Herpin D; Piron J; Bajou B; Lecasble M
    Ann Cardiol Angeiol (Paris); 1989 Oct; 38(8):503-7. PubMed ID: 2574560
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.